12 Health Care Stocks Moving In Thursday's After-Market Session
Portfolio Pulse from Benzinga Insights
In Thursday's after-market session, several health care stocks experienced significant price movements. Notable gainers included Cardio Diagnostics Holdings, TC BioPharm, and Seres Therapeutics, while Cue Biopharma and enVVeno Medical were among the biggest losers.
September 26, 2024 | 8:31 pm
News sentiment analysis
Sort by:
Ascending
NEGATIVE IMPACT
Cue Biopharma's stock fell by 27.8% to $0.33, with a market cap of $15.9 million.
The sharp decline indicates negative news or sentiment, likely leading to further short-term downward pressure.
CONFIDENCE 90
IMPORTANCE 70
RELEVANCE 80
NEGATIVE IMPACT
enVVeno Medical's stock declined by 15.34% to $3.81, with a market cap of $50.7 million.
The decline suggests negative sentiment or news, potentially leading to continued short-term weakness.
CONFIDENCE 85
IMPORTANCE 60
RELEVANCE 70
POSITIVE IMPACT
Cardio Diagnostics Holdings saw a 16.8% increase in its stock price, reaching $0.29, with a market cap of $6.9 million.
The significant price increase suggests positive sentiment or news, likely leading to short-term upward momentum.
CONFIDENCE 90
IMPORTANCE 70
RELEVANCE 80
POSITIVE IMPACT
Seres Therapeutics shares increased by 6.01% to $0.88, with a market cap of $134.0 million.
The upward movement suggests positive developments or investor interest, likely boosting short-term stock performance.
CONFIDENCE 85
IMPORTANCE 60
RELEVANCE 70
POSITIVE IMPACT
TC BioPharm's stock rose by 6.69% to $6.16, with a market cap of $3.1 million.
The stock's rise indicates positive market reaction, potentially due to favorable news or investor sentiment.
CONFIDENCE 85
IMPORTANCE 60
RELEVANCE 70